Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing

investors.com/news/technology/novo-nordisk-obesity-deal-septerna-gpcr

Novo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.
The post Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-05-14 13:06:39.
The Entire Business World on a Single Page. Free to Use →